Peripartale Antikoagulation

Melden Sie sich bitte hier kostenlos und unverbindlich an, um den Inhalt vollständig einzusehen und weitere Services von www.medmedia.at zu nutzen.

Zur Anmeldung

AutorIn: Ass.-Prof. Priv.-Doz. Dr. Eva Schaden, EDIC

Bereichsleit. Geburtshilfliche Anästhesie, Univ.-Klinik für Anästhesie, Allgem. Intensivmed. und Schmerztherapie, Medizinische Universität Wien


1 Morris J.M. et al.: Incidence and risk factors for pulmonary embolism in the postpartum period. J Thromb Haemost 2010; 8 (5): 998–1003
2 Barco S. et al: Pregnancy and venous thromboembolism. Semin Thromb Hemost 2013; 39 (5): 549–58
3 Sultan A.A. et al.: Risk of first venous thromboembolism in and around pregnancy: a population-based cohort study. Br J Haematol 2012; 156 (3): 366–73
4 Bergrem A. et al.: Resistance to activated protein C is a risk factor for pregnancy-related venous thrombosis in the absence of the F5 rs6025 (factor V Leiden) polymorphism. Br J Haematol 2011; 154 (2): 241–7
5 Anderson F.A. Jr. et al.: Risk factors for venous thromboembolism. Circulation 2003; 107 (23 Suppl. 1): I9–16
6 Bates S.M. et al.: American College of Chest Physicians: VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed.: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (2 Suppl.): e691S–736S
7 Gould M.K. et al.: Prevention of VTE in Nonorthopedic Surgical Patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (2 Suppl.): e227S–e277S

GA 06|2014

Herausgeber: em. o. Univ.-Prof. Dr. Sepp Leodolter, Universitätsklinik für Frauenheilkunde, Wien
Publikationsdatum: 2014-12-17